ResearcherUniversity of VirginiaActive in the last 2 years
William J. Kane
Matched on ORCID iD 0000-0002-6051-8210; OpenAlex author ID A5052589390. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 4
- PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer. First author DOI 10.3390/biom15070948↗
- Survival benefit associated with screening of patients at elevated risk for pancreatic cancer. Co-author DOI 10.1002/jso.27784↗
- A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-2945↗
- Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells. Co-author DOI 10.1073/pnas.2009899117↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Todd W. Bauer · 4 shared papers, 2020–2025 · strength 0.76
- Paper PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer. DOI 10.3390/biom15070948↗
- Paper Survival benefit associated with screening of patients at elevated risk for pancreatic cancer. DOI 10.1002/jso.27784↗
- Paper A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer. DOI 10.1158/0008-5472.can-22-2945↗
- Sarbajeet Nagdas · 2 shared papers, 2024–2025 · strength 0.50
- Xiaolong Wei · 2 shared papers, 2020–2025 · strength 0.40
- Andrew Y. Wang · 1 shared paper, 2024 · strength 0.20
- Allan Tsung · 1 shared paper, 2024 · strength 0.20
- Reid B. Adams · 1 shared paper, 2024 · strength 0.20
- Vanessa M. Shami · 1 shared paper, 2024 · strength 0.20
- Kyoung Eun Lee · 1 shared paper, 2024 · strength 0.17
- Michelle C Barbeau · 1 shared paper, 2024 · strength 0.17
- Matthew J Lazzara · 1 shared paper, 2024 · strength 0.17
- Brooke A. Brown · 1 shared paper, 2024 · strength 0.17
- Ben Z. Stanger · 1 shared paper, 2024 · strength 0.17
- Jason Robert Pitarresi · 1 shared paper, 2024 · strength 0.17
- M. Celeste Simon · 1 shared paper, 2024 · strength 0.17
- Harun Öztürk · 1 shared paper, 2020 · strength 0.09
- Mazhar Adli · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.